Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 283, Issue 5 27-5, 2002, Pages

  Sisson, Thomas H ^a   Hanson, Kerstin E ^a   Subbotina, Natalya ^a   Patwardhan, Anjali ^a   Hattori, Noboru ^a   Simon, Richard H ^a  

^a 6301 MSRB3 ^*  (United States)

Author keywords

Bleomycin; Plasmin; Plasminogen activator; Tetracycline

Indexed keywords

BLEOMYCIN; DOXYCYCLINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR FORMATION; TRANSGENIC MOUSE;

EID: 0036838357     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00049.2002     Document Type: Article

References (32)

1. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, and Chapman HJ. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322: 890-897, 1990.
2. Davis GE, Pintar Allen KA, Salazar R, and Maxwell SA. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 114: 917-930, 2001.
3. Dohi M, Hasegawa T, Yamamoto K, and Marshall BC. Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. Am J Respir Crit Care Med 162: 2302-2307, 2000.
4. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, and Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97: 232-237, 1996.
5. Gross TJ, Simon RH, and Sitrin RG. Expression of urokinasetype plasminogen activator by rat pulmonary alveolar epithelial cells. Am J Respir Cell Mol Biol 3: 449-456, 1990.
6. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, and Seeger W. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161: 454-462, 2000.
7. Gunther A, Mosavi P, Ruppert C, Heinemann S, Temmesfeld B, Velcovsky HG, Morr H, Grimminger F, Walmrath D, and Seeger W. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease. Thromb Haemost 83: 853-860, 2000.
8. Hart DA, Whidden P, Green F, Henkin J, and Woods DE. Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin Invest Med 17: 69-76, 1994.
9. Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, and Drew AF. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 106: 1341-1350, 2000.
10. Hattori N, Sisson TH, Xu Y, Desai TJ, and Simon RH. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung. Am J Physiol Lung Cell Mol Physiol 277: L573-L579, 1999.
11. Hattori N, Sisson TH, Xu Y, and Simon RH. Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo. Hum Gene Ther 10: 215-222, 1999.
12. Hu B, Kapila YL, Buddhikot M, Shiga M, and Kapila S. Coordinate induction of collagenase-1, stromelysin-1 and urokinase plasminogen activator (uPA) by the 120-kDa cell-binding fibronectin fragment in fibrocartilaginous cells: uPA contributes to activation of procollagenase-1. Matrix Biol 19: 657-669, 2000.
13. Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, and Maunder RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 261: L240-L248, 1991.
14. Ikeda T, Hirose N, Koto H, Hirano H, and Shigematsu N. Fibrin deposition and fibrinolysis in the pathogenesis of pulmonary fibrosis. Nihon Kyobu Shikkan Gakkai Zasshi 27: 448-451, 1989.
15. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, and Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93: 10933-10938, 1996.
16. Kotani I, Sato A, Hayakawa H, Urano T, Takada Y, and Takada A. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res 77: 493-504, 1995.
17. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, and Elias JA. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(l). J Exp Med 194: 809-821, 2001.
18. Legrand C, Polette M, Tournier JM, de Bentzmann S, Huet E, Monteau M, and Birembaut P. uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp Cell Res 264: 326-336, 2001.
19. Milner JM, Elliott SF, and Cawston TE. Activation of procollagenases is a key control point in cartilage collagen degradation: Interaction of serine and metalloproteinase pathways. Arthritis Rheum 44: 2084-2096, 2001.
20. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, and Comoglio PM. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11: 4825-4833, 1992.
21. Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, and Comoglio PM. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem 270: 603-611, 1995.
22. Olman MA, Mackman N, Gladson CL, Moser KM, and Loskutoff DJ. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest 96: 1621-1630, 1995.
23. Ray P, Tang W, Wang P, Homer R, Kuhn C, Flavell RA III, and Elias JA. Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J Clin Invest 100: 2501-2511, 1997.
24. Salgado S, Garcia J, Vera J, Siller F, Bueno M, Miranda A, Segura A, Grijalva G, Segura J, Orozco H, Hernandez-Pando R, Fafutis M, Aguilar LK, Aguilar-Cordova E, and Armendariz-Borunda J. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther 2: 545-551, 2000.
25. Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, and Mori H. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 33: 569-576, 2001.
26. Sisson TH, Hattori N, Xu Y, and Simon RH. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinasetype plasminogen activator genes. Hum Gene Ther 10: 2315-2323, 1999.
27. Sugahara K, Iyama K, Kuroda MJ, and Sano K. Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats. J Pathol 186: 90-98, 1998.
28. Swaisgood CM, French EL, Noga C, Simon RH, and Ploplis VA. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157: 177-187, 2000.
29. Tichelaar JW, Lu W, and Whitsett JA. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J Biol Chem 275: 11858-11864, 2000.
30. Wilberding JA, Ploplis VA, McLennan L, Liang Z, Cornelissen I, Feldman M, Deford ME, Rosen ED, and Castellino FJ. Development of pulmonary fibrosis in fibrinogen-deficient mice. Ann NY Acad Sci 936: 542-548, 2001.
31. Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, and Nukiwa T. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 156: 1937-1944, 1997.
32. Yi ES, Williams ST, Lee H, Malicki DM, Chin EM, Yin S, Tarpley J, and Ulich TR. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol 149: 1963-1970, 1996.